ctSearch Results
Original Query
What is cancer Bexxar regimen?
Search Results
- cancer bexxar regimen
Bexxar is a combination of drugs used to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Bexxar is made up of a monoclonal antibody called tositumomab and a form of tositumomab that is linked to a radioactive substance called iodine I 131. It is a type of radioimmunoconjugate. Also called Bexxar regimen and tositumomab and iodine I 131 tositumomab. Bexxar regimen is a combination of drugs used to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Bexxar regimen is made up of a monoclonal antibody called tositumomab and a form of tositumomab that is linked to a radioactive substance called iodine I 131. It is a type of radioimmunoconjugate. Also called Bexxar and tositumomab and iodine I 131 tositumomab. Regimen is a treatment plan that specifies the dosage, the schedule, and the duration of treatment. Cancer is a term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.
Preview- One can view, patients with advanced-stage follicular lymphomaa cancer generally considered incurablewho had not been previously treated with any other form of therapy received a single course of treatment with the Bexxar therapeutic regimen, a radioactive antibody injected into the bloodstream that targets and kills cancer cells. Of the 76 patients enrolled in the study, 95 percent responded to the treatment, and 75 percent had a complete response, meaning no evidence of cancer remained. Antibody is a protein made by plasma cells (a type of white blood cell) in response to an antigen (a substance that causes the body to make a specific immune response). Each antibody can bind to only one specific antigen. The purpose of this binding is to help destroy the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen. An antibody is a type of immunoglobulin. Therapeutic, having to do with treating disease and helping healing take place. Stage is the extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body. Response is in medicine, an improvement related to treatment. Therapy, treatment. Complete response is the disappearance of all signs of cancer in response to treatment. This does not always mean the cancer has been cured. Also called complete remission. Radioactive, giving off radiation.
- It really is obvious that, METHODS Seventy-six patients with stage III or IV follicular lymphoma received as initial therapy a single course of treatment with 131. I-tositumomab therapy (registered as Tositumomab and Iodine I 131 Tositumomab Tositumomab and iodine I 131 tositumomab is a combination of drugs used to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Tositumomab and iodine I 131 tositumomab is made up of a monoclonal antibody called tositumomab and a form of tositumomab that is linked to a radioactive substance called iodine I 131. It is a type of radioimmunoconjugate. Also called Bexxar and Bexxar regimen. Iodine I 131 tositumomab is a drug used with another drug to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Iodine I 131 tositumomab is a form of the monoclonal antibody tositumomab that is linked to the radioactive substance iodine I 131. It is a type of radioimmunoconjugate. Iodine is an element that is necessary for the body to make thyroid hormone. It is found in shellfish and iodized salt. Tositumomab is a drug used together with another drug to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Tositumomab binds to a protein called CD20, which is found on the surface of B cells, and may kill cancer cells. It is a type of monoclonal antibody.
- Finally, you can determine, the BEXXAR therapeutic regimen represents a new generation of cancer treatments because it is targeted specifically at non-Hodgkins lymphoma cells, is given at a dose tailored for each individual patient, and is delivered in a short treatment course, said Debra Frei-Lahr, M.D., an MUSC medical oncologist and hematologist. Most important, BEXXAR allows us to offer real hope to patients with follicular non-Hodgkins lymphoma who have exhausted other options. Oncologist is a doctor who specializes in treating cancer. Some oncologists specialize in a particular type of cancer treatment. For example, a radiation oncologist specializes in treating cancer with radiation. Hematologist is a doctor who specializes in treating blood disorders. Medical oncologist is a doctor who specializes in diagnosing and treating cancer using chemotherapy, hormonal therapy, biological therapy, and targeted therapy. A medical oncologist often is the main health care provider for someone who has cancer. A medical oncologist also gives supportive care and may coordinate treatment given by other specialists.
NEW: Try our Cancer Expert Fact Search, and get direct access to our Knowledge Base (KB).
Disclaimer: On occasion, search results will contain fragmented, and erroneous (misspelled, incorrect grammar and malformatted) text. It is not possible, for our Bots to automatically correct these, afterall they represent the corpus created by individuals and/or other Bots and who have placed it on the Internet. Keep in mind, Cancer Expert Search is a search engine, and we are required to return search results as closely resembling their original format, when they were discovered by our Bots (including all errors).
